Literature DB >> 26021191

Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.

Thomas M Runge1, Julian A Abrams2, Nicholas J Shaheen3.   

Abstract

Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC), a disease with increasing burden in the Western world, especially in white men. Risk factors for BE include obesity, tobacco smoking, and gastroesophageal reflux disease (GERD). EAC is the most common form of esophageal cancer in the United States. Risk factors include GERD, tobacco smoking, and obesity, whereas nonsteroidal antiinflammatory drugs and statins may be protective. Factors predicting progression from nondysplastic BE to EAC include dysplastic changes on esophageal histology and length of the involved BE segment. Biomarkers have shown promise, but none are approved for clinical use.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Barrett’s esophagus; Epithelium; Esophageal adenocarcinoma; Gastroesophageal reflux disease

Mesh:

Substances:

Year:  2015        PMID: 26021191      PMCID: PMC4449458          DOI: 10.1016/j.gtc.2015.02.001

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  160 in total

Review 1.  Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy.

Authors:  Stuart Jon Spechler
Journal:  Med Clin North Am       Date:  2002-11       Impact factor: 5.456

2.  Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables.

Authors:  P S Rabinovitch; G Longton; P L Blount; D S Levine; B J Reid
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

3.  Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.

Authors:  B J Reid; L J Prevo; P C Galipeau; C A Sanchez; G Longton; D S Levine; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

4.  Gastroesophageal reflux disease in monozygotic and dizygotic twins.

Authors:  Alan J Cameron; Jesper Lagergren; Christer Henriksson; Olof Nyren; G Richard Locke; Nancy L Pedersen
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

5.  Risk factors for Barrett's esophagus: a case-control study.

Authors:  Massimo Conio; Rosangela Filiberti; Sabrina Blanchi; Roberto Ferraris; Santino Marchi; Paolo Ravelli; Gabriella Lapertosa; Gaetano Iaquinto; Renato Sablich; Riccardo Gusmaroli; Hugo Aste; Attilio Giacosa
Journal:  Int J Cancer       Date:  2002-01-10       Impact factor: 7.396

Review 6.  Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.

Authors:  Nicholas Shaheen; David F Ransohoff
Journal:  JAMA       Date:  2002-04-17       Impact factor: 56.272

7.  Prevalence of Barrett's esophagus in asymptomatic individuals.

Authors:  Lauren B Gerson; Katerina Shetler; George Triadafilopoulos
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

Review 8.  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.

Authors:  Douglas A Corley; Karla Kerlikowske; Rajiv Verma; Patricia Buffler
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

9.  Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995.

Authors:  A Paloma Vizcaino; Victor Moreno; Rene Lambert; D Maxwell Parkin
Journal:  Int J Cancer       Date:  2002-06-20       Impact factor: 7.396

10.  Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.

Authors:  Benjamin Avidan; Amnon Sonnenberg; Thomas G Schnell; Gregorio Chejfec; Adrienne Metz; Stephen J Sontag
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

View more
  58 in total

Review 1.  From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.

Authors:  Ravindran Caspa Gokulan; Monica T Garcia-Buitrago; Alexander I Zaika
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

Review 2.  Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-07-06       Impact factor: 8.262

Review 3.  [Barrett's esophagus].

Authors:  J Labenz
Journal:  Internist (Berl)       Date:  2016-11       Impact factor: 0.743

Review 4.  The mechanisms of radioresistance in esophageal squamous cell carcinoma and current strategies in radiosensitivity.

Authors:  Guang-Zong Chen; Hong-Cheng Zhu; Wang-Shu Dai; Xiao-Ning Zeng; Jin-Hua Luo; Xin-Chen Sun
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 5.  Barrett's esophagus: best practices for treatment and post-treatment surveillance.

Authors:  Nabil M Mansour; Hashem B El-Serag; Sharmila Anandasabapathy
Journal:  Ann Cardiothorac Surg       Date:  2017-03

6. 

Authors:  Stéphane Groulx; Heather Limburg; Marion Doull; Scott Klarenbach; Harminder Singh; Brenda J Wilson; Brett Thombs
Journal:  CMAJ       Date:  2020-11-23       Impact factor: 8.262

7.  Association between coffee or tea drinking and Barrett's esophagus or esophagitis: an Italian study.

Authors:  R A Filiberti; V Fontana; A De Ceglie; S Blanchi; E Grossi; D Della Casa; T Lacchin; M De Matthaeis; O Ignomirelli; R Cappiello; A Rosa; M Foti; F Laterza; V D'Onofrio; G Iaquinto; M Conio
Journal:  Eur J Clin Nutr       Date:  2017-05-10       Impact factor: 4.016

8.  Neutrophil-Lymphocyte Ratio as a Marker of Progression from Non-Dysplastic Barrett's Esophagus to Esophageal Adenocarcinoma: a Cross-Sectional Retrospective Study.

Authors:  Vinicius J Campos; Guilherme S Mazzini; José F Juchem; Richard R Gurski
Journal:  J Gastrointest Surg       Date:  2019-11-19       Impact factor: 3.452

Review 9.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

Review 10.  Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.

Authors:  Amrit K Kamboj; David A Katzka; Prasad G Iyer
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.